In conclusion, DPP4i may efficiently attenuate the pathogenesis of AMLN diet-induced NASH in mice by suppressing lipotoxicity-induced apoptosis, possibly by modulating hepatic DPP4 expression. The gene discussed is DPP4; the disease is metabolic dysfunction-associated steatohepatitis.